mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | USA300TCH1516_ALE | 111,512 | 0 | A | G | 32.4% | 186.6 / 135.4 | 142 | S194S (TCA→TCG) | USA300HOU_RS00520 | putative lipoprotein |
| * | USA300TCH1516_ALE | 111,516 | 0 | C | A | 30.4% | 255.8 / 141.9 | 138 | Q196K (CAA→AAA) | USA300HOU_RS00520 | putative lipoprotein |
| * | USA300TCH1516_ALE | 512,643 | 0 | A | G | 21.6% | 153.6 / 39.3 | 74 | intergenic (+711/‑6052) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
| Marginal new junction evidence (lowest skew 10 of 1026 shown) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | USA300TCH1516_ALE | 1426517 = | 79 (0.780) | 53 (0.620) | 24/150 | 3.8 | 44.6% | intergenic (‑248/+724) | pstS/cvfB | Phosphate‑binding protein PstS/Conserved virulence factor B |
| ? | USA300TCH1516_ALE | 1910715 = | NA (NA) | intergenic (+248/‑307) | crcB_2/USA300TCH1516_01771 | Putative fluoride ion transporter CrcB/hypothetical protein | |||||
| * | ? | USA300TCH1516_ALE | 1910672 = | NA (NA) | 69 (0.780) | 24/156 | 4.1 | NA | intergenic (+205/‑350) | crcB_2/USA300TCH1516_01771 | Putative fluoride ion transporter CrcB/hypothetical protein |
| ? | USA300TCH1516_ALE | 1910712 = | NA (NA) | intergenic (+245/‑310) | crcB_2/USA300TCH1516_01771 | Putative fluoride ion transporter CrcB/hypothetical protein | |||||
| * | ? | CP000731 | = 12646 | 119 (0.330) | 44 (0.210) | 17/166 | 6.5 | 30.5% | coding (140/675 nt) | USA300HOU_pUSA300HOUMR0016 | IS257 transposase |
| ? | USA300TCH1516_ALE | 36410 = | 91 (0.970) | coding (142/675 nt) | USA300HOU_RS00140 | hypothetical protein | |||||
| * | ? | USA300TCH1516_ALE | = 76354 | 35 (0.340) | 44 (0.470) | 16/166 | 6.9 | 57.7% | coding (140/246 nt) | USA300HOU_RS00140 | hypothetical protein |
| ? | USA300TCH1516_ALE | = 76356 | NA (NA) | coding (142/246 nt) | USA300HOU_RS00140 | hypothetical protein | |||||
| * | ? | USA300TCH1516_ALE | 36403 = | 98 (0.960) | 44 (0.470) | 16/166 | 6.9 | 43.1% | coding (149/675 nt) | USA300HOU_RS00140 | hypothetical protein |
| ? | USA300TCH1516_ALE | = 76347 | 26 (0.280) | coding (133/246 nt) | USA300HOU_RS00140 | hypothetical protein | |||||
| * | ? | USA300TCH1516_ALE | = 344426 | 110 (1.080) | 18 (0.200) | 12/156 | 7.9 | 16.1% | intergenic (+25/‑183) | yezG_1/USA300HOU_RS01545 | putative antitoxin YezG/hypothetical protein |
| ? | USA300TCH1516_ALE | = 344433 | 92 (1.040) | intergenic (+32/‑176) | yezG_1/USA300HOU_RS01545 | putative antitoxin YezG/hypothetical protein | |||||
| * | ? | USA300TCH1516_ALE | = 75986 | 125 (1.230) | 16 (0.190) | 11/148 | 7.9 | 12.6% | intergenic (+44/‑229) | USA300HOU_RS00335/USA300HOU_RS00140 | hypothetical protein/hypothetical protein |
| ? | USA300TCH1516_ALE | = 76003 | 120 (1.430) | intergenic (+61/‑212) | USA300HOU_RS00335/USA300HOU_RS00140 | hypothetical protein/hypothetical protein | |||||
| * | ? | USA300TCH1516_ALE | 42564 = | 102 (1.000) | 25 (0.320) +TACATTATAAAATACATATC |
10/140 | 7.9 | 24.1% | coding (1402/1524 nt) | USA300TCH1516_00035 | hypothetical protein |
| ? | USA300TCH1516_ALE | = 2479065 | 100 (0.980) | intergenic (+21/+119) | USA300HOU_RS12765/hrtA_2 | hypothetical protein/Putative hemin import ATP‑binding protein HrtA | |||||
| * | ? | USA300TCH1516_ALE | 42564 = | 102 (1.000) | 25 (0.320) +TACATTATAAAATACATATC |
10/140 | 7.9 | 24.0% | coding (1402/1524 nt) | USA300TCH1516_00035 | hypothetical protein |
| ? | USA300TCH1516_ALE | 1803072 = | NA (NA) | coding (796/807 nt) | USA300HOU_RS12765 | hypothetical protein | |||||
| * | ? | USA300TCH1516_ALE | = 1955657 | 124 (1.220) | 18 (0.200) | 12/158 | 8.0 | 13.8% | intergenic (‑711/+411) | gdmA/lukDv_2 | Lantibiotic gallidermin/Leucotoxin LukDv |
| ? | USA300TCH1516_ALE | = 1955663 | 116 (1.300) | intergenic (‑717/+405) | gdmA/lukDv_2 | Lantibiotic gallidermin/Leucotoxin LukDv | |||||